Agmatine diminishes pro-inflammatory response by modulating IL-1β and NF-κB expression in the prefrontal cortex and reverses behavioral impairments following chronic social isolation in rats


Zortul H., Shabani A., ÜNAL G., ARICIOĞLU F.

Pharmacology Biochemistry and Behavior, cilt.263, 2026 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 263
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.pbb.2026.174178
  • Dergi Adı: Pharmacology Biochemistry and Behavior
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE, Psycinfo
  • Anahtar Kelimeler: Agmatine, Anxiety disorders, Fluoxetine, Pro-inflammatory cytokines, Social isolation
  • Marmara Üniversitesi Adresli: Evet

Özet

Chronic social isolation (SI) is a significant psychosocial stressor associated with psychiatric disorders, including anxiety and depression, as well as cognitive decline. Emerging evidence suggests that neuroinflammation and oxidative stress in critical brain regions, such as prefrontal cortex (PFC), play a pivotal role in these conditions. Agmatine (AGM), an endogenous amine characterized by neuromodulatory properties, has exhibited anti-inflammatory, anxiolytic, and antidepressant effects. The objective of this study was to evaluate whether AGM could attenuate the behavioral and neuroinflammatory effects induced by chronic SI in rats, in comparison to fluoxetine (FLU). According to the study, male Sprague Dawley rats were divided into control, SI, SI + FLU (15 mg/kg, i.p.), and SI + AGM (40 mg/kg, i.p.) groups (n = 8 per group). After five weeks of SI, treatments were administered daily for nine days. Behavioral phenotypes were assessed using the open field (OF), elevated plus maze (EPM), novel object recognition (NOR), and marble burying (MB) tests, followed by the dissection of PFC region of the brain. Interleukin-1β (IL-1β) and nuclear factor kappa B (NF-κB) mRNA expressions are measured in PFC. Compared to controls, SI rats showed significant behavioral deficits, including decreased locomotion (OF), increased anxiety-like behavior (EPM), impaired recognition memory (NOR), and heightened compulsive-like behavior (MB). These behavioral changes were accompanied by significantly elevated IL-1β and NF-κB mRNA levels in PFC. Treatment with AGM markedly reduced all behavioral deficits, restoring performance across all tests. This behavioral improvement was also reflected by a significant decrease in interleukin-1β (IL-1β) and nuclear factor kappa B (NF-κB) expression, bringing levels close to control values. FLU provided only partial relief of these behavioral and molecular alterations. This study shows that chronic SI induces robust behavioral alterations associated with a pro-inflammatory state in PFC. AGM effectively reverses anxiety-like behaviors and cognitive impairments, likely by suppressing the NF-κB pro-inflammatory cascade.